欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/V/0425/001
药品名称
Ventimaxx 25 microgram/ml oral solution for horses
活性成分
Clenbuterol hydrochloride 25.0 microgram/ml
剂型
Oral solution
上市许可持有人
Alfasan Nederland B.V.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Cyprus (CY)
Iceland (IS)
Czechia (CZ)
Ventimaxx, 25μg/ml, Oral solution
Ireland (IE)
Romania (RO)
Austria (AT)
Slovakia (SK)
France (FR)
Slovenia (SI)
Spain (ES)
Croatia (HR)
Portugal (PT)
United Kingdom (Northern Ireland) (XI)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Germany (DE)
Estonia (EE)
Denmark (DK)
Hungary (HU)
Belgium (BE)
Bulgaria (BG)
Luxembourg (LU)
许可日期
2025/04/02
最近更新日期
2025/04/02
药物ATC编码
QR03CC13 clenbuterol
申请类型
TypeLevel1:
food
TypeLevel2:
Pharmaceutical
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
PuAR Ventimaxx
Date of last change:2025/07/22
Final Product Information
|
Common_spc_label_pl_ventimaxx
Date of last change:2025/04/02
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase